These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39094669)

  • 1. Recommendations for Deprescribing of Medication in the Last Phase of Life: An International Delphi Study.
    Elsten EECM; Pot IE; Geijteman ECT; Hedman C; van der Heide A; van der Kuy PHM; Fürst CJ; Eychmüller S; van Zuylen L; van der Rijt CCD
    J Pain Symptom Manage; 2024 Nov; 68(5):443-455.e2. PubMed ID: 39094669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation.
    Lavan AH; Gallagher P; Parsons C; O'Mahony D
    Age Ageing; 2017 Jul; 46(4):600-607. PubMed ID: 28119312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deprescribing tool for use in older Australians with life-limiting illnesses and limited life expectancy: a modified-Delphi study protocol.
    Shrestha S; Poudel A; Steadman KJ; Nissen LM
    BMJ Open; 2021 Apr; 11(4):e043766. PubMed ID: 33795304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing Tool for Older PeoPle with Limited-life Expectancy (De-TOPPLE) version 1: Development and validation using a modified Delphi technique.
    Shrestha S; Poudel A; Steadman KJ; Nissen LM
    Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):15-27. PubMed ID: 37264733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review on methods for developing and validating deprescribing tools for older adults with limited life expectancy.
    Shrestha S; Poudel A; Forough AS; Steadman KJ; Nissen LM
    Int J Pharm Pract; 2023 Mar; 31(1):3-14. PubMed ID: 36472946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better drug use in advanced disease: an international Delphi study.
    Huisman BAA; Geijteman ECT; Dees MK; van Zuylen L; van der Heide A; Perez RSGM
    BMJ Support Palliat Care; 2023 Oct; 13(e1):e115-e121. PubMed ID: 30446489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.
    Farrell B; Tsang C; Raman-Wilms L; Irving H; Conklin J; Pottie K
    PLoS One; 2015; 10(4):e0122246. PubMed ID: 25849568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deprescribing in palliative care.
    Thompson J
    Clin Med (Lond); 2019 Jul; 19(4):311-314. PubMed ID: 31308110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus-based recommendations for the development and expansion of palliative day care clinics in Germany: results of a Delphi study.
    Stiel S; Ernst A; Apolinarski B; Röwer HAA; de Jong L; Burger B; Schütte S; Schneider N; Damm K; Stahmeyer JT; Herbst FA
    BMC Palliat Care; 2024 May; 23(1):116. PubMed ID: 38702653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study.
    Bahat G; Ilhan B; Erdogan T; Oren MM; Karan MA; Burkhardt H; Denkinger M; Garfinkel D; Cruz-Jentoft AJ; Morrissey Y; Onder G; Pazan F; Tommelein E; Topinkova E; van der Velde N; Petrovic M
    Drugs Aging; 2021 Jun; 38(6):513-521. PubMed ID: 33847948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active deprescribing program in chronic kidney disease patients undergoing haemodialysis.
    George JS; Joseph R; Thomas ETA; John GP; Siby A; Nair MM
    Nephrology (Carlton); 2021 Nov; 26(11):890-897. PubMed ID: 34240512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advancement of an intermediate level of outpatient palliative care - A Delphi study].
    van Baal K; Frerichs H; Stahmeyer JT; Hemmerling M; Schulze C; Schneider N; Stiel S
    Z Evid Fortbild Qual Gesundhwes; 2023 Jun; 179():29-38. PubMed ID: 37173274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A National Modified Delphi Consensus Process to Prioritize Experiences and Interventions for Antipsychotic Medication Deprescribing Among Adult Patients With Critical Illness.
    Jaworska N; Makuk K; Krewulak KD; Niven DJ; Ismail Z; Burry LD; Mehta S; Fiest KM
    Crit Care Explor; 2022 Dec; 4(12):e0806. PubMed ID: 36506828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Important to Older Adults Who Disagree With a Deprescribing Recommendation.
    Weir KR; Shang J; Choi J; Rana R; Vordenberg SE
    JAMA Netw Open; 2023 Oct; 6(10):e2337281. PubMed ID: 37819657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "… Above All, It's a Matter of  This Person's Quality of Life": Health Care Professionals' Perspectives on Deprescribing in Older Patients With Limited Life Expectancy.
    Lundby C; Graabæk T; Ryg J; Søndergaard J; Pottegård A; Nielsen DS
    Gerontologist; 2020 Apr; 60(3):439-449. PubMed ID: 31433836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel.
    Page AT; Potter K; Clifford R; McLachlan AJ; Etherton-Beer C
    Intern Med J; 2016 Oct; 46(10):1189-1197. PubMed ID: 27527376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing in Older Adults With Cancer and Limited Life Expectancy: An Integrative Review.
    Brokaar EJ; van den Bos F; Visser LE; Portielje JEA
    Am J Hosp Palliat Care; 2022 Jan; 39(1):86-100. PubMed ID: 33739162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tackling potentially inappropriate prescriptions in older adults: development of deprescribing criteria by consensus from experts in Colombia, Argentina, and Spain.
    De Las Salas R; Vaca-González C; Eslava-Schmalbach J; Torres-Espinosa C; Figueras A
    BMC Geriatr; 2023 Oct; 23(1):682. PubMed ID: 37864147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus Recommendations for Sick Day Medication Guidance for People With Diabetes, Kidney, or Cardiovascular Disease: A Modified Delphi Process.
    Watson KE; Dhaliwal K; Robertshaw S; Verdin N; Benterud E; Lamont N; Drall KM; McBrien K; Donald M; Tsuyuki RT; Campbell DJT; Pannu N; James MT;
    Am J Kidney Dis; 2023 May; 81(5):564-574. PubMed ID: 36470530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.